JAMA Cardiology·1 OctCardiovascular-Kidney-Metabolic Overlap in Patients Hospitalized for Heart FailureCohort study of 725,205 peopleHeart failurePaper
JACC Advances·24 SepComparison of Artificial Intelligence-Driven Echocardiographic Assessment of Diastolic Function With the ASE GuidelinesStudy in peopleBiomarkersPaper
Circulation Heart Failure·21 SepClonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection FractionCohort study of 654 peopleClonal hematopoiesis of indeterminate potentialPaper
Handbook of Experimental Pharmacology·13 SepClinical Evidence of Cardioprotective Effects of SGLT2 InhibitorsReviewInterventionsPaper
JACC Case Reports·3 SepPatient Engagement as the Rate-Limiting Step: Normalizing Value-Based Care Teams to Address CKM Treatment GapsTrial in peopleInterventionsPaper
JACC Heart Failure·3 SepResidual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary StudyRandomised trial in 1,902 peopleHeart failurePaper
European Heart Journal Acute Cardiovascular Care·19 AugFrailty Assessment and the Risk of Major Adverse Cardiac Events after Elective SurgeryCohort study in peopleBiomarkersPaper
Annals of Internal Medicine·17 AugLongitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults : An Observational StudyCohort study of 8,454 peopleCardiovascular diseasePaper
Clinical Journal of the American Society of Nephrology·7 AugMetabolic Dysfunction-Associated Steatotic Liver Disease, Cardiovascular, and Kidney Disease: Triple ChallengesReviewCardiovascular-kidney-metabolic syndromePaper
AHA Scientific Sessions 2025 Abstract·3 NovOptimal GDMT Use According to Frailty Status Following Diagnosis of HFrEF Among Medicare Fee for Service BeneficiariesStudy in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovAssociations of baseline and longitudinal changes in MASLD with risk of heart failure events in type 2 diabetes and overweight or obesity: the Look Action for Health in Diabetes (Look AHEAD) Trial Liver Ancillary StudyTrial in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovA Polypill Strategy for Lipid Lowering and Anti-Platelet Therapy After Acute Coronary Syndrome: A Pilot Randomized Controlled TrialTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovIntensive lifestyle intervention, MASLD, and cardiovascular outcomes in type 2 diabetes and overweight or obesity: the Look Action for Health in Diabetes (Look AHEAD) trial Liver Ancillary StudyTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovNon-invasive Diastolic Stress Testing in a Large Observational Cohort Study: Insights from the Dallas Heart StudyStudy in peopleBiomarkersPaper
AHA Scientific Sessions 2025 Abstract·3 NovAssociation of natriuretic peptide concentration with lifetime risk of heart failure in adults with diabetes mellitus: a pooled cohort analysisStudy in peopleBiomarkersPaper
AHA Scientific Sessions 2025 Abstract·3 NovSymptoms of Bladder Incontinence Are Associated with Worse Functional Status and Quality of Life in Heart Failure with Preserved Ejection FractionStudy in peoplePopulationsPaper
ADA Scientific Sessions 2025 Abstract·13 JunNatriuretic Peptide Screening Predicts Survival Outcomes in Individuals with Diabetes without Known Heart FailureStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunGeneralizability of SELECT and SURMOUNT-MMO Trial Criteria to the U.S. OMM-Eligible Adult PopulationStudy in peoplePopulationsPaper